The Week in Review: January 12 – January 19, 2018

Friday, January 19, 2018 News Recap: Research & Discoveries: Blood test for early detection of 8 cancers looks promising. Scientists have developed a blood test that can detect eight common cancer types through assessment of the levels of circulating proteins and mutations in cell-free DNA. The test, called CancerSEEK, clinically detected cancers of the ovary, liver, stomach, pancreas, esophagus, colorectum, lung, or breast. CancerSEEK tests wer...

The Week in Review: October 20 – October 27, 2017

Friday, October 27, 2017 News Recap: Patient and Caregiver input is requested by BC Pharmacare on AbbVie’s combo of glecaprevir and pibrentasvir (GP) for Genotypes 1-6. We need to hear your voice by November 8, 2017!  AbbVie’s “GP” combo is pan-genotypic (works for all genotypes). Liver Meeting 2017: I’m A HCV Patient – Show Me What I Need to Know! Why reinvent the wheel? The good folks over at HCV New Drugs have put together this great overview o...

DAA Era Linked with Better Liver Transplant Outcomes

HCV treatment improvements reflected in graft, patient survival WASHINGTON -- Patients with chronic hepatitis C have done better after liver transplant in the era of direct-acting agents (DAAs) against the virus, a researcher said here. In a retrospective analysis of transplant outcomes, the DAA era was associated with a 36% drop in mortality a year after transplant, according to George Cholankeril, MD, of the University of Tennessee Health Science Cen